The Utilization Pattern of Caspofungin in an Educational Hospital

The Utilization Pattern of Caspofungin in an Educational Hospital

Purpose: Caspofungin is prescribed for systemic treatment of fungal infections and correct prescription pattern is an issue of importance. Hence in this study the Caspofungin utilization and the frequency rate of medication errors were investigated at a training hospital in a developing country. Met...

Full description

Bibliographic Details
Main Authors:	Soodeh Ramezaninejad, Atefeh Amouzegar, Sohrab Aghabeigi, Maryam Farasati Nasab, Mitra Ranjbar, Mahin Jamshidi, Behrooz Ghanbari, Nashmin Pakdaman, Maryam Khorsani
Format:	Article
Language:	English
Published:	Research Center for Rational Use of Drugs (RCRUD) 2019-12-01
Series:	Journal of Pharmaceutical Care
Subjects:	Caspofungin Candida infection Antimicrobial therapy Antifungal drug Medication error
Online Access:	https://jpc.tums.ac.ir/index.php/jpc/article/view/266

Similar Items

Proteomic Analysis of Caspofungin-Induced Responses in Planktonic Cells and Biofilms of Candida albicans
by: Peng Li, et al.
Published: (2021-02-01)

Peripheral Candidal Suppurative Thrombophlebitis Successfully Treated with Caspofungin in a Bariatric Surgery Patient
by: Özgür GÜNAL, et al.
Published: (2012-12-01)

Caspofungin in Recurrent Fluconazole Resistant Candida Esophagitis Treatment
by: Çiğdem EROL, et al.
Published: (2007-09-01)

Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association
by: Andrea Duminuco, et al.
Published: (2021-11-01)

Susceptibility to caspofungin is regulated by temperature and is dependent on calcineurin in Candida albicans
by: Lijun Zheng, et al.
Published: (2023-12-01)

Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight
by: Meng-Ju Li, et al.
Published: (2012-01-01)

Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata
by: Parisa Aryamloo, et al.
Published: (2019-06-01)

Antifungal Susceptibility of Oral <i>Candida</i> Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
by: Naemah Alkhars, et al.
Published: (2023-05-01)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
by: Gerardo Becerra Victorio, et al.

Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin
by: Harshali Manish Yadav, et al.
Published: (2017-01-01)

Susceptibility Pattern of Caspofungin-Coated Gold Nanoparticles Against Clinically Important Candida Species
by: Zahra Salehi, et al.
Published: (2021-09-01)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01)

Evaluating the Inappropriate Prescribing and Utilization of Caspofungin, a Four-Year Analysis at a Teaching Hospital in Saudi Arabia
by: Abdulwahab Aldrees, et al.
Published: (2021-12-01)

Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
by: Iching G. Yu, et al.
Published: (2021-04-01)

Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
by: Giuseppe Buda De Cesare, et al.
Published: (2022-12-01)

Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics
by: C Sanz-Rodriguez, et al.
Published: (2005-11-01)

In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method
by: Qianting Yang, et al.
Published: (2022-09-01)

Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
by: Andrew S. Wagner, et al.
Published: (2023-08-01)

The Effects of Holothurin and Caspofungin on the Vaginal Cell Inflammation Parameters of the Rattus norvegicus Strain Post Induction of Candida albicans
by: Handayani S, et al.
Published: (2023-04-01)

Drug susceptibility pattern of candida species isolated from skin of neonates to fluconazole, amphotericin B and caspofungin
by: Soraya Ghorbani, et al.
Published: (2017-07-01)

Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia
by: Roya Sattarzadeh Badkoubeh, et al.
Published: (2022-08-01)

Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis
by: Irina Ullmann, et al.
Published: (2022-06-01)

Synergistic Activity of the Human Lactoferricin-Derived Peptide hLF1-11 in Combination with Caspofungin against Candida Species
by: Roberta Fais, et al.
Published: (2022-08-01)

New Formulations Loading Caspofungin for Topical Therapy of Vulvovaginal Candidiasis
by: Noelia Pérez-González, et al.
Published: (2021-12-01)

Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review
by: Gül Ruhsar YILMAZ, et al.
Published: (2024-03-01)

Evaluation of a Novel <i>FKS1</i> R1354H Mutation Associated with Caspofungin Resistance in <i>Candida auris</i> Using the CRISPR-Cas9 System
by: Maiko Kiyohara, et al.
Published: (2023-04-01)

Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae
by: Maytham Hussein, et al.
Published: (2022-01-01)

Caspofungin-Loaded Formulations for Treating Ocular Infections Caused by <i>Candida</i> spp.
by: Noelia Pérez-González, et al.
Published: (2023-04-01)

Rituximab Utilization Evaluation with Focused on Available Evidence for Off-Labeled Indications
by: Sohrab Aghabeigi, et al.
Published: (2019-08-01)

A Markerless CRISPR-Mediated System for Genome Editing in Candida auris Reveals a Conserved Role for Cas5 in the Caspofungin Response
by: Craig L. Ennis, et al.
Published: (2021-12-01)

Synergism between the Antidepressant Sertraline and Caspofungin as an Approach to Minimise the Virulence and Resistance in the Dermatophyte <i>Trichophyton rubrum</i>
by: Carlos H. Lopes Rocha, et al.
Published: (2022-08-01)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
by: Döring Michaela, et al.
Published: (2012-07-01)

Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt
by: Amira M El-Ganiny, et al.
Published: (2021-03-01)

Are Systemic Voriconazole and Caspofungin Ototoxic? An Experimental Study with Rats
by: Emine Aydın, et al.
Published: (2012-09-01)

Outcomes of caspofungin use in the treatment of Candida-related urinary tract infections, a case series
by: Laila Rkieh, et al.
Published: (2022-01-01)

<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure
by: Farha Husain, et al.
Published: (2022-12-01)

Efficacy and safety of caspofungin for patients with hepatic insufficiency
by: Xiaoyun Ran, et al.
Published: (2022-06-01)

Medication-Use Evaluation of Caspofungin In intensive Care Units of Alzahra Hospital, Isfahan, Iran, in Year 2015
by: Javaher Pourmohammad, et al.
Published: (2018-04-01)

Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran
by: Maral Gharaghani, et al.
Published: (2020-06-01)

Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species
by: Ali Rezaei-Matehkolaei, et al.
Published: (2017-03-01)